Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial

Journal:

Nature Communications

Published:

2025-12-04

DOI:

10.1038/s41467-025-66747-z

Affiliations:

8

Authors:

8

Go to article

Institutions	Authors	Share
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Spain	1.000000	0.13
Catalan Institute of Oncology (ICO), Spain	1.000000	0.13
Instituto de Investigación Hospital 12 de Octubre (i+12), Spain	1.000000	0.13
Virgen del Rocío University Hospital, Spain	1.000000	0.13
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	1.000000	0.13
Catalan Ornithological Institute (ICO), Spain	1.000000	0.13
Hospital del Mar, Spain	1.000000	0.13
La Fe University Hospital, Spain	1.000000	0.13

Interested in Oncology and Carcinogenesis?